Matthew Sloan, Michael S Borofsky
Journal: The Urologic clinics of North America 2025;52(3):329-342
PMID: 40610081
Hypocitraturia is one of the most common and correctable risk factors for nephrolithiasis. It is primarily caused by alterations in acid-base status, with several identified etiologies driving its pathogenesis. Diagnosis is made by at least one 24-hour urine study. Treatment involves identifying and reversing potential causes, followed by dietary modifications and alkali supplementation. Numerous new supplements have emerged in this space, gaining availability and popularity with patients. This article reviews pathophysiology, etiology, diagnosis, and treatment of hypocitraturia in the context of urolithiasis.
Copyright © 2025 Elsevier Inc. All rights reserved.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.